Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
Abstract Clopidogrel is the most common and widely used antiplatelet agent for patients with coronary artery disease following confirmation by electrocardiographic studies. The nonresponsiveness of patients to clopidogrel and the possibility of testing for clopidogrel resistance by platelet function...
Saved in:
Main Authors: | Bhawani Yasassri Alvitigala (Author), Lallindra Viranjan Gooneratne (Author), Godwin Roger Constantine (Author), Rajapaksha Arachchige Namal Kumarasiri Wijesinghe (Author), Liyanage Dona Ashanthi Menuka Arawwawala (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016) -
Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
by: Arzu Gunes, et al.
Published: (2010) -
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022) -
An Integrated Multidisciplinary Circuit Led by Hospital and Community Pharmacists to Implement Clopidogrel Pharmacogenetics in Clinical Practice
by: Joan Francesc Mir, et al.
Published: (2023) -
Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case
by: M. A. Andreyanova, et al.
Published: (2018)